Hyperuricemia in psoriasis and psoriatic arthritis

被引:1
|
作者
Mohammed, Jinan Q. [1 ]
Mathkhor, Abdulsatar J. [2 ]
机构
[1] Basrah Teaching Hosp, Dept Dermatol, Basrah, Iraq
[2] Basrah Teaching Hosp, Dept Rheumatol, Basrah, Iraq
来源
关键词
Hyperuricemia; Psoriasis; Psoriatic Arthritis; Serum Uric Acid; SERUM URIC-ACID; DISEASE SEVERITY;
D O I
10.4328/ACAM.20965
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Psoriasis is a common, chronic, disfiguring, inflammatory, non-infectious skin disorder associated with cardiovascular diseases, obesity, diabetes mellitus, hypertension, and hyperlipidemia. The association between psoriasis and hyperuricemia was also reported. Therefore, we aimed to evaluate serum uric acid levels in psoriasis and psoriatic arthritis (PsA) patients. Material and Methods: The study involved one hundred twenty (64 males and 56 females) patients, including 88 with psoriasis vulgaris and 32 with PsA, matched for age and sex with 120 healthy controls. Disease activity scores using Psoriasis Area Severity Index (PASI) score and Disease Activity Score using 28 joints (DAS28) were estimated for all patients. In addition, serum uric acid levels were measured for all the study participants. Results: Serum uric acid levels were 6.2 +/- 2.5 mg/dl and 4.1 +/- 1.2 mg/dl for psoriatic patients and controls, respectively. High serum uric acid levels were associated with high PASI scores and high DAS28 in psoriatic and PsA patients, respectively. Discussion: Psoriasis and PsA are significantly associated with hyperuricemia. Hyperuricemia is correlated to high PASI and high DAS28.
引用
收藏
页码:426 / 429
页数:4
相关论文
共 50 条
  • [41] The Prevalence of Psoriatic Arthritis in People With Psoriasis
    Ibrahim, G.
    Waxman, R.
    Helliwell, P. S.
    [J]. ARTHRITIS CARE & RESEARCH, 2009, 61 (10) : 1373 - 1378
  • [42] CERVICAL SPINE IN PSORIASIS + IN PSORIATIC ARTHRITIS
    KAPLAN, D
    FRANK, L
    NATHANSON, L
    PLOTZ, CM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1964, 23 (01) : 50 - &
  • [43] Apremilast: A Review in Psoriasis and Psoriatic Arthritis
    Gillian M. Keating
    [J]. Drugs, 2017, 77 : 459 - 472
  • [44] Prediction of psoriatic arthritis in patients with psoriasis
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (09): : E507 - E507
  • [45] Leflunomide for psoriasis and psoriatic arthritis.
    Liang, GC
    Barr, WG
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S323 - S323
  • [46] Outcome Measures in Psoriasis and Psoriatic Arthritis
    Kim N.
    Gottlieb A.B.
    [J]. Current Dermatology Reports, 2013, 2 (3) : 159 - 163
  • [47] Tofacitinib for the treatment of psoriasis and psoriatic arthritis
    Ighani, Arvin
    Georgakopoulos, Jorge R.
    Yeung, Jensen
    [J]. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2020, 155 (04): : 400 - 410
  • [48] New biologics for psoriasis and psoriatic arthritis
    Rozenblit, Mariya
    Lebwohl, Mark
    [J]. DERMATOLOGIC THERAPY, 2009, 22 (01) : 56 - 60
  • [49] Family aggregation in psoriasis and psoriatic arthritis
    Miller, M.
    Ueng, J.
    Pellett, F. J.
    Shanmugarajah, S.
    Schentag, C. T.
    Rosen, C. T.
    Gladman, D. D.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1412 - 1412
  • [50] Burden of Disease: Psoriasis and Psoriatic Arthritis
    Wolf-Henning Boehncke
    Alan Menter
    [J]. American Journal of Clinical Dermatology, 2013, 14 : 377 - 388